Evidence map›Paper›PMID 42804491›Full record

ArticleHuman vaccines & immunotherapeutics2026

Brief report: Effectiveness and safety of recombinant zoster vaccine in inflammatory bowel disease patients aged 18 years and older: A matched cohort and self-controlled case series study.

Maheen Humayun, Lina S Sy, Emily Rayens, Lei Qian, Jun Wu, Bradley K Ackerson, Yi Luo, Yanjun Cheng, Avanish R Patel, Zendi Solano and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Maheen HumayunKaiser Permanente Southern California, Pasadena, CA, USA.ORCID 0000-0003-2172-3753
Lina S SyKaiser Permanente Southern California, Pasadena, CA, USA.
Emily RayensKaiser Permanente Southern California, Pasadena, CA, USA.
Lei QianKaiser Permanente Southern California, Pasadena, CA, USA.
Jun WuKaiser Permanente Southern California, Pasadena, CA, USA.
Bradley K AckersonKaiser Permanente Southern California, Pasadena, CA, USA.
Yi LuoKaiser Permanente Southern California, Pasadena, CA, USA.
Yanjun ChengKaiser Permanente Southern California, Pasadena, CA, USA.
Avanish R PatelKaiser Permanente Southern California, Pasadena, CA, USA.
Zendi SolanoKaiser Permanente Southern California, Pasadena, CA, USA.
Britta AmundsenKaiser Permanente Southern California, Pasadena, CA, USA.
Justine De JesusKaiser Permanente Southern California, Pasadena, CA, USA.
Jennifer H KuKaiser Permanente Southern California, Pasadena, CA, USA.
Elizabeth Chmielewski-YeeGSK, Rockville, MD, USA.
Driss OraichiGSK, Rockville, MD, USA.
Harry SeifertGSK, Rockville, MD, USA.
Huifeng YunGSK, Rockville, MD, USA.
Hung Fu TsengKaiser Permanente Southern California, Pasadena, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Individuals with inflammatory bowel disease (IBD) are at increased risk of herpes zoster (HZ). Using a matched cohort design, we evaluated the vaccine effectiveness (VE) of recombinant zoster vaccine (RZV) against HZ among IBD patients aged ≥18 years. Within the Kaiser Permanente Southern California population, individuals who received 2 RZV doses were matched up to 1:3 to RZV-unvaccinated individuals. Individuals were followed from 31 days after the receipt of the 2

Indexed as

Herpes ZosterHerpes Zoster VaccineInflammatory Bowel DiseasesVaccine EfficacyAdolescentAdultAgedCaliforniaCase-Control StudiesCohort StudiesFemaleHumansMaleMiddle AgedVaccinationVaccines, SyntheticHerpes Zoster VaccineVaccines, SyntheticCrohn’s diseaseflareInflammatory bowel diseaserecombinant zoster vaccineulcerative colitisvaccine effectiveness

Identifiers

PMID42804491
PMCPMC13625710

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.